Membrane/NN
receptors/NNS
for/IN
aldosterone/NN
:/:
a/DT
novel/JJ
pathway/NN
for/IN
mineralocorticoid/NN
action/NN
./.

Rapid/JJ
nongenomic/JJ
in/FW
vitro/FW
effects/NNS
of/IN
aldosterone/NN
on/IN
intracellular/JJ
electrolytes/NNS
,/,
cell/NN
volume/NN
,/,
and/CC
Na(+)-H+/JJ
antiport/NN
have/VBP
been/VBN
found/VBN
in/IN
human/JJ
mononuclear/JJ
leukocytes/NNS
(/(
HML/NN
)/)
./.
=====
Binding/NN
of/IN
125I-labeled/JJ
aldosterone/NN
to/TO
plasma/NN
membranes/NNS
of/IN
HML/NN
shares/VBZ
important/JJ
features/NNS
with/IN
these/DT
functional/JJ
data/NNS
./.
=====
This/DT
includes/VBZ
a/DT
very/RB
low/JJ
apparent/JJ
dissociation/NN
constant/NN
(/(
Kd/NN
)/)
of/IN
0.1/CD
nM/NN
for/IN
both/CC
aldosterone/NN
and/CC
the/DT
effect/NN
on/IN
the/DT
Na(+)-H(+)-antiport/NN
,/,
a/DT
high/JJ
turnover/NN
rate/NN
,/,
and/CC
the/DT
almost/RB
exclusive/JJ
binding/NN
selectivity/NN
for/IN
aldosterone/NN
./.
=====
Dexamethasone/NN
,/,
RU/NN
26988/CD
,/,
corticosterone/NN
,/,
ouabain/NN
,/,
amiloride/NN
,/,
and/CC
18-hydroxyprogesterone/NN
were/VBD
inactive/JJ
as/IN
ligands/NNS
./.
=====
Deoxycorticosterone/NN
acetate/NN
had/VBD
an/DT
intermediate/JJ
activity/NN
with/IN
an/DT
apparent/JJ
Kd/NN
of/IN
100/CD
nM/NN
./.
=====
These/DT
findings/NNS
are/VBP
the/DT
first/JJ
to/TO
demonstrate/VB
membrane/NN
binding/NN
of/IN
aldosterone/NN
being/VBG
compatible/JJ
with/IN
major/JJ
aspects/NNS
of/IN
its/PRP$
nongenomic/JJ
effects/NNS
./.